Marianne van Hage, professor at Karolinska Institutet, has received Europe's most prestigious research award in allergy - the Paul Ehrlich Prize. She is the first Swede ever to receive the award, thanks to her groundbreaking research in molecular allergology and on the tick-induced food allergy, the alpha-Gal syndrome.
The European Academy of Allergy and Clinical Immunology (EAACI) has awarded Marianne van Hage , senior professor of clinical immunology at the Department of Medicine Solna , the prestigious Paul Ehrlich Prize for 2025.
The prize is EAACI's highest distinction and is awarded to outstanding researchers whose pioneering work has contributed to a deeper scientific understanding of allergic diseases and immunological mechanisms.
"I feel great joy and gratitude for the recognition this award represents, and I am honored to be the first Swedish recipient," says Marianne van Hage.
Marianne van Hage is being awarded the prize for her significant pioneering work in molecular allergology and for her major scientific contributions to the understanding of the alpha-gal syndrome, and its underlying mechanisms.
She has demonstrated the clinical value of molecular allergy diagnostics by showing how it enables more precision-based diagnoses, which has had a significant impact on the investigation of allergic diseases.
Furthermore, Marianne van Hage has shown how, at the molecular allergen level, it is possible to predict the development of respiratory and food allergies several years before manifest allergic disease occurs.
More on the Paul Ehrlich Prize
The prize is named after the German physician and immunologist Paul Ehrlich, who was awarded the Nobel Prize in Physiology or Medicine in 1908 for his discoveries about the immune system.
Marianne van Hage is the first Swede to receive this honor. Previous recipients include prominent researchers such as Emma Guttman-Yassky (2024, USA), Kari Nadeau (2023, USA), Sebastian Johnston (2018, United Kingdom), and Cezmi Akdis (2016, Switzerland).
Source: EAACI
